Published on: 08/27/2026
This news was posted by Oregon Today News
Description

The U.S. Food and Drug Administration has approved the first oral medicine designed to treat adults with dermatomyositis, a rare and debilitating autoimmune condition that attacks the muscles and skin.
Other Related News
08/27/2026
82726 - Sheriffs Office SAR helps Rescue person stuck on Mt Yoran On August 26th a littl...
08/27/2026
Netflix is set to release a new game show based on a classic movie but it is already facin...
08/27/2026
The Pittsburgh Steelers close out the preseason on the road tonight against the Buffalo Bi...
08/27/2026
Detectives are investigating the death of a 2-year-old child in rural Central Point
08/27/2026
